The Role of Myeloid-Derived Suppressor Cells (MDSCs) in the Development and/or Progression of Endometriosis-State of the Art
review
OA: gold
CC0
⤵ 12 in-corpus citations
Abstract
Endometriosis (EMS) is a common gynecological disease characterized by the presence of endometrial tissue outside the uterus. Approximately 10% of women around the world suffer from this disease. Recent studies suggest that endometriosis has potential to transform into endometriosis-associated ovarian cancer (EAOC). Endometriosis is connected with chronic inflammation and changes in the phenotype, activity, and function of immune cells. The underlying mechanisms include quantitative and functional disturbances of neutrophils, monocytes/macrophages (MO/MA), natural killer cells (NK), and T cells. A few reports have shown that immunosuppressive cells such as regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs) may promote the progression of endometriosis. MDSCs are a heterogeneous population of immature myeloid cells (dendritic cells, granulocytes, and MO/MA precursors), which play an important role in the development of immunological diseases such as chronic inflammation and cancer. The presence of MDSCs in pathological conditions correlates with immunosuppression, angiogenesis, or release of growth factors and cytokines, which promote progression of these diseases. In this paper, we review the impact of MDSCs on different populations of immune cells, focusing on their immunosuppressive role in the immune system, which may be related with the pathogenesis and/or progression of endometriosis and its transformation into ovarian cancer.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (97)
- Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage. via openalex
- Alteration of Myeloid-Derived Suppressor Cells, Chronic Inflammatory Cytokines, and Exosomal miRNA Contribute to the Peritoneal Immune Disorder of Patients With Endometriosis via openalex
- CD33<sup>+</sup>CD14<sup>+</sup>CD11b<sup>+</sup>HLA‐DR<sup>−</sup> monocytic myeloid‐derived suppressor cells recruited and activated by CCR9/CCL25 are crucial for the pathogenic progression of endometriosis via openalex
- Clinical implication for endometriosis associated with ovarian cancer via openalex
- Endometriosis: abnormal endometrium and dysfunctional immune response via openalex
- Endometriosis, a disease of the macrophage via openalex
- Endometriosis and endometriosis-associated cancers: new insights into the molecular mechanisms of ovarian cancer development via openalex
- Endometriosis and Ovarian Cancer: an Integrative Review (Endometriosis and Ovarian Cancer) via openalex
- Endometriosis and risk of ovarian cancer: what do we know? via openalex
- Endometriosis and risks for ovarian, endometrial and breast cancers: A nationwide cohort study via openalex
- Endometriosis and the risk of cancer with special emphasis on ovarian cancer via openalex
- Endometriosis-associated ovarian carcinomas: insights into pathogenesis, diagnostics, and therapeutic targets—a narrative review via openalex
- Endometriosis-associated ovarian neoplasia via openalex
- Evaluation of M1 and M2 macrophages in ovarian endometriomas from women affected by endometriosis at different stages of the disease via openalex
- Expansion of monocytic myeloid-derived suppressor cells in endometriosis patients: A pilot study via openalex
- Expression of inflammatory cytokines in serum and peritoneal fluid from patients with different stages of endometriosis via openalex
- Extrapelvic endometriosis: a rare entity or an under diagnosed condition? via openalex
- Extra‐pelvic endometriosis: A review via openalex
- Extrapelvic Endometriosis: A Systematic Review via openalex
- High prevalence of autoimmune diseases in women with endometriosis: a case-control study via openalex
- High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis via openalex
- Immunological Basis of the Endometriosis: The Complement System as a Potential Therapeutic Target via openalex
- Increased IL-25 levels in the peritoneal fluid of patients with endometriosis via openalex
- Involvement of immune cells in the pathogenesis of endometriosis via openalex
- Macrophages Are Alternatively Activated in Patients with Endometriosis and Required for Growth and Vascularization of Lesions in a Mouse Model of Disease via openalex
- MDSCs drive the process of endometriosis by enhancing angiogenesis and are a new potential therapeutic target via openalex
- New insights in the pathophysiology of ovarian cancer and implications for screening and prevention via openalex
- Notch signaling controls sprouting angiogenesis of endometriotic lesions via openalex
- Pathogenèse de l'endométriose via openalex
- Reduction of myeloid derived suppressor cells by inhibiting Notch pathway prevents the progression of endometriosis in mice model via openalex
- Risk factors in progression from endometriosis to ovarian cancer: a cohort study based on medical insurance data via openalex
- Serum and Ectopic Endometrium from Women with Endometriosis Modulate Macrophage M1/M2 Polarization via the Smad2/Smad3 Pathway via openalex
- Stem cells in endometrium and their role in the pathogenesis of endometriosis via openalex
- The association between endometriosis and autoimmune diseases: a systematic review and meta-analysis via openalex
- The role of the B lymphocytes in endometriosis: A systematic review via openalex
- Understanding malignant transformation of endometriosis: imaging features with pathologic correlation via openalex
- Unraveling the two entities of endometrioid ovarian cancer: A single center clinical experience via openalex
- W2904061041 via openalex
- W2917660987 via openalex
- W2931512726 via openalex
- W2938046619 via openalex
- W2945534157 via openalex
- W2945950379 via openalex
- W2954320913 via openalex
- W2958978924 via openalex
- W2968643365 via openalex
- W3001066245 via openalex
- W3009319701 via openalex
- W3010011098 via openalex
- W3011954154 via openalex
- W3026977895 via openalex
- W3040762998 via openalex
- W3045021985 via openalex
- W3047346291 via openalex
- W3084101009 via openalex
- W3084463300 via openalex
- W3109289585 via openalex
- W4211140426 via openalex
- W6678815053 via openalex
- W1494453913 via openalex
- W6732729624 via openalex
- W1903506892 via openalex
- W1993192622 via openalex
- W1999995687 via openalex
- W2004150448 via openalex
- W2042786949 via openalex
- W2045970621 via openalex
- W2048270768 via openalex
- W2048434210 via openalex
- W2073606915 via openalex
- W2102310375 via openalex
- W2109424201 via openalex
- W2132587402 via openalex
- W2151551477 via openalex
- W2159803625 via openalex
- W2163825883 via openalex
- W2165064029 via openalex
- W2438866487 via openalex
- W2471500324 via openalex
- W2559991009 via openalex
- W2565033598 via openalex
- W2568525023 via openalex
- W2568903712 via openalex
- W2568946517 via openalex
- W2732589699 via openalex
- W2742440809 via openalex
- W2748794530 via openalex
- W2765508732 via openalex
- W2771183993 via openalex
- W2774310048 via openalex
- W2782485041 via openalex
- W2793492950 via openalex
- W2803115351 via openalex
- W2809626402 via openalex
- W2864371843 via openalex
- W2898028485 via openalex
- W2901646825 via openalex
Cited by (12)
- PBMC-derived FGF, PDGF, VEGF and GM-CSF secretion in endometriosis: a case–control in vitro study 2026
- Dissecting the causal effects of interleukin receptor-related factors and the risk of developing endometriosis: a two-sample Mendelian randomization study 2025
- Lactate-mediated immune suppression and MDSC expansion in endometriosis: Mechanisms and nanoparticle-targeted therapies 2025
- Endometrial Receptivity in Women with Endometriosis 2024
- Immune Checkpoints in Endometriosis—A New Insight in the Pathogenesis 2024
- Isolation of myeloid-derived suppressor cells (MDSC) from endometriotic mice model and their immunomodulatory functions 2023
- Insight into the Potential Mechanisms of Endocrine Disruption by Dietary Phytoestrogens in the Context of the Etiopathogenesis of Endometriosis 2023
- Immune and endocrine regulation in endometriosis: what we know 2023
- Expression of Gal-9 on Dendritic Cells and Soluble Forms of TIM-3/Gal-9 in Patients Suffering from Endometriosis 2023
- Clinical Value of the PD-1/PD-L1/PD-L2 Pathway in Patients Suffering from Endometriosis 2022
- Symptoms based endometriosis prediction using machine learning 2021
- Mesenchymal Stromal Cells Isolated from Ectopic but Not Eutopic Endometrium Display Pronounced Immunomodulatory Activity In Vitro 2021
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:24:43.494969+00:00
License: CC0
· commercial use OK